Target intelligence / Profile preview

Cytosine residue in DNA (C (when referring to DNA sequence notation); otherwise, none in this context)

Target
C (when referring to DNA sequence notation); otherwise, none in this context
Molecular classification
Pyrimidine nucleobase, DNA base/residue, (Not a protein or classic druggable target)
01

Overview

Cytosine is one of the four major nitrogenous bases (pyrimidine class, chemical formula C₄H₅N₃O) present in DNA, where it forms stable hydrogen bonds with guanine through Watson-Crick base pairing. In eukaryotic cells, cytosine residues in DNA can be methylated at the 5-position to form 5-methylcytosine, an epigenetic modification that plays critical roles in gene regulation, development, and disease. Aberrant modification or mutagenic deamination of cytosine contributes to genome instability and is implicated in carcinogenesis and other diseases

Other names
Cytosine base in DNADNA cytosine5-methylcytosine (for methylated forms)
02

Mechanism of action

Not applicable for cytosine residues directly\n(DNA methyltransferase inhibitors block methylation of cytosine residues in DNA, leading to changes in gene expression)

03

Biological functions

Genetic information storageBase pairing (with guanine)Substrate for DNA methylation (epigenetic regulation)Template for DNA replication and RNA transcription
04

Disease associations

Cancer (especially through aberrant cytosine methylation)Other (e.g., epigenetic regulation in developmental disorders and some metabolic/acquired diseases)
05

Safety considerations

Not applicable to cytosine residue itselfTherapeutic modulation of enzymes affecting cytosine methylation can cause global epigenetic changes, raising potential for toxicity and off-target effects.
06

Interacting drugs

None directly for cytosine residues
07

Biomarkers

5-methylcytosine (and related modifications like 5-hydroxymethylcytosine) are used as biomarkers for epigenetic state in cancer and other diseases

Beyond the preview

Go deeper on Cytosine residue in DNA (C (when referring to DNA sequence notation); otherwise, none in this context).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytosine residue in DNA (C (when referring to DNA sequence notation); otherwise, none in this context).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call